Indapamide and Salivary hypersecretion - a phase IV clinical study of FDA data

Summary:

Salivary hypersecretion is reported as a side effect among people who take Indapamide (indapamide), especially for people who are female, 60+ old, also take Methotrexate, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Salivary hypersecretion when taking Indapamide. It is created by eHealthMe based on reports of 21,640 people who have side effects when taking Indapamide from the FDA, and is updated regularly.

What is Indapamide?

Indapamide has active ingredients of indapamide. It is often used in high blood pressure. eHealthMe is studying from 22,152 Indapamide users. Check the latest studies of Indapamide.

What is Salivary hypersecretion?

Salivary hypersecretion (excess saliva secretion) is found to be associated with 790 drugs and 1,336 conditions by eHealthMe. Check the latest studies of Salivary hypersecretion.

On Jul, 07, 2026

21,640 people reported to have side effects when taking Indapamide.
Among them, 18 people (0.08%) have Salivary hypersecretion.

Could Indapamide cause Salivary hypersecretion?

Among these 18 people:

What is the gender of people who have Salivary hypersecretion when taking Indapamide? *

female: 58.82 %
male: 41.18 %

What is the age of people who have Salivary hypersecretion when taking Indapamide? *

What are other drugs people take besides Indapamide? *

What are other side effects people have besides Salivary hypersecretion? *

Headache (pain in head): 10 people, 55.56%
Insomnia (sleeplessness): 10 people, 55.56%
Stress And Anxiety: 6 people, 33.33%
Mobility Decreased (ability to move is reduced): 6 people, 33.33%
Memory Loss: 6 people, 33.33%
Neck Pain: 6 people, 33.33%
Depression: 6 people, 33.33%
Confusional State: 6 people, 33.33%
Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 6 people, 33.33%
Dyskinesia (abnormality or impairment of voluntary movement): 6 people, 33.33%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 55.56%
Polyarthritis (arthritis which involves 5 or more joints simultaneously): 4 people, 22.22%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 11.11%
Diabetes: 2 people, 11.11%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 11.11%
Asthma: 2 people, 11.11%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 5.56%
Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 5.56%
Psychotic Disorder: 1 person, 5.56%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Indapamide and have Salivary hypersecretion?

- Check whether Salivary hypersecretion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Indapamide:

Indapamide (22,152 reports)

Browse all side effects of Indapamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Salivary hypersecretion:

Salivary hypersecretion (790 drugs)

Browse all the conditions that are associated with Salivary hypersecretion:

Salivary hypersecretion (1,336 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on indapamide (the active ingredients of Indapamide) and Indapamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.